Cardiology Credibility HealthReveal has secured a relationship with the American College of Cardiology for its TRANSFORM studies, signaling credibility in cardiology-focused AI. This can be leveraged to expand adoption within hospital cardiology departments and chronic disease programs that seek evidence-based, personalized interventions. Target hospitals and health systems with strong cardiology services and risk-adjusted care initiatives to drive pilot programs and expansions.

EMR Ready HealthReveal has a history of integrating with EMR systems, including Epic through ACPNY Valley Stream Medical Office. This lowers deployment friction and accelerates time-to-value for health systems seeking clinical AI that lands in existing workflows. Position as an interoperable AI layer that can be paired with major EMRs to support guideline-directed care at the point of care.

Chronic AI Value The core offering focuses on chronic cardiometabolic conditions by predicting patient risks and prescribing tailored interventions to reduce adverse events and costs. This aligns with the payer and provider shift toward value-based care and may unlock opportunities for pilots or contracts with health systems looking to improve quality metrics and readmission rates.

Security First Security posture is evident through a stack including Sucuri and Cloudflare DNS, which can be a differentiator when selling to large hospitals with stringent data protection requirements. Highlight readiness for compliant deployment, data governance, and secure hosting as part of the sales pitch to risk-averse health networks.

Growth Partners With venture backing and a history of strategic funding, HealthReveal presents a growth opportunity through co-sell partnerships with payers, health systems, and technology partners. Despite modest current revenue, there is potential to scale via pilots, expand to additional specialties beyond cardiology, and broaden EMR integrations to accelerate adoption.